Process for the Preparation of Pyrimidine Compounds
AssigneeAstraZeneca UK Limited
InventorsLee Newton, Mark Bailey
Life of this patent
Estimating the term…
Loading patent…
AssigneeAstraZeneca UK Limited
InventorsLee Newton, Mark Bailey
Estimating the term…
A process for the preparation of a compound of Formula (I) and intermediates useful therein are provided. The process comprises reacting a compound of formula R1—CO—CH2-E with a compound of formula R2—CHX1X2 in the presence of a compound of formula R3R4N—C(═NH)NH2 and a catalyst, thereby to form a dihydropyrimidine; and oxidising the dihydropyrimidine to form the compound of Formula (1). R1 is H or an alkyl group; R2 is H, an alkyl or aryl group; R3 and R4 are each independently H, alkyl or aryl, or R3 and R4 are linked to form, together with the nitrogen to which they are attached to form a 5 to 7 membered heterocyclic ring; E is H, an unsubstituted alkyl group, and aryl group or an electron withdrawing group; and X1 and X2 are each independently leaving groups, or X1 and X2 together represent ═O.
A process for the preparation of a compound of Formula (1):
A compound of Formula (2a), and tautomers thereof:
A process for the preparation of a compound of Formula (2a) and tautomers thereof:
A process for the preparation of a compound of Formula (1):
A process for the preparation of a compound of Formula (3):
A process for the preparation of a compound of Formula (3):
A compound of formula (CH3)2CH—CO—CH2—CO2—C3H7.
Dependencies are inferred from the claim text.